Equity Overview
Price & Market Data
Price: $55.08
Daily Change: +$1.10 / 2.00%
Daily Range: $54.30 - $55.48
Market Cap: $0
Daily Volume: 26,792
Performance Metrics
1 Week: 2.95%
1 Month: 8.72%
3 Months: 9.09%
6 Months: 33.62%
1 Year: 128.7%
YTD: 7.10%
Details
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.